Tumor cell plasticity in uveal melanoma: Microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns

American Journal of Pathology

Volumn 169, Issue 4, 2006, Pages 1376-1389

  Folberg, Robert ^a   Arbieva, Zarema ^a   Moses, Jonas ^a   Hayee, Amin ^a   Sandal, Tone ^a   Kadkol, ShriHari ^a   Lin, Amy Y ^a   Valyi Nagy, Klara ^a   Setty, Suman ^a   Leach, Lu ^a   Chévez Barrios, Patricia ^b   Larsen, Peter ^a   Majumdar, Dibyen ^a   Pe'er, Jacob ^c   Maniotis, Andrew J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYTOKINE; GROWTH DIFFERENTIATION FACTOR 15; HERMES ANTIGEN; KI 67 ANTIGEN; PROTEOCHONDROITIN SULFATE; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; TUMOR MARKER;

ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR MIMICRY; NUCLEOTIDE SEQUENCE; PLASTICITY; PRIORITY JOURNAL; TUMOR CELL; UVEA MELANOMA; CELL CULTURE; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; IMMUNOHISTOCHEMISTRY; MELANOMA; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHENOTYPE; TUMOR GENE; UVEA TUMOR; VASCULARIZATION;

GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MELANOMA; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; UVEAL NEOPLASMS;

EID: 34247105188     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.060223     Document Type: Article

References (60)

1. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LMG, Pe'er J, Trent JM, Meltzer PS, Hendrix MJC: Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999, 155:739-752
2. Folberg R, Hendrix MJ, Maniotis AJ: Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 2000, 156:361-381
3. Folberg R, Maniotis AJ: Vasculogenic mimicry. APMIS 2004, 112:508-525
4. Maniotis AJ, Chen X, Garcia C, DeChristopher PJ, Wu D, Pe'er J, Folberg R: Control of melanoma morphogenesis, endothelial survival, and perfusion by extracellular matrix. Lab Invest 2002, 82:1031-1043
5. Clarijs R, Otte-Holler I, Ruiter DJ, de Waal RM: Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma. Invest Ophthalmol Vis Sci 2002, 43:912-918
6. Chen X, Ai Z, Rasmussen M, Bajcsy P, Auvil L, Welge M, Leach L, Vangveeravong S, Maniotis AJ, Folberg R: Three-dimensional reconstruction of extravascular matrix patterns and blood vessels in human uveal melanoma tissue: techniques and preliminary findings. Invest Ophthalmol Vis Sci 2003, 44:2834-2840
7. Potgens AJG, van Altena MC, Lubsen NH, Ruiter DJ, de Waal RMW: Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor. Am J Pathol 1996, 148:1203-1217
8. Ruf W, Seftor EA, Petrovan RJ, Weiss RM, Gruman LM, Margaryan NV, Seftor REB, Miyagi Y, Hendrix MJC: Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry. Cancer Res 2003, 63:5381-5389
9. Chen HB, Chen L, Zhung JK, Chow VW, Wu BQ, Wang ZH, Cheng SB, Chew EC: Expression of laminin in metastatic melanoma cell lines with different metastatic potential. Anticancer Res 2001, 21:505-508
10. Chen X, Maniotis AJ, Majumdar D, Pe'er J, Folberg R: Uveal melanoma cell staining for CD34 and assessment of tumor vascularity. Invest Ophthalmol Visual Sci 2002, 43:2533-2539
11. Hao XS, Sun BC, Zhang SW, Zhao XL: Correlation between the expression of collagen IV, VEGF and vasculogenic mimicry. Zhonghua Zhong Liu Za Zhi 2003, 25:524-526
12. Daniels KJ, Boldt HC, Martin JA, Gardner LM, Meyer M, Folberg R: Expression of type VI collagen in uveal melanoma: role in pattern formation and tumor progression. Lab Invest 1996, 75:55-66
13. Lin AY, Maniotis AJ, Valyi-Nagy K, Majumdar D, Setty S, Kadkol S, Leach L, Pe'er J, Folberg R: Distinguishing fibrovascular septa from vasculogenic mimicry patterns. Arch Pathol Lab Med 2005, 129:884-892
14. Smetsers TFCM, van de Westerlo EMA, ten Dam GB, Clarijs R, Versteeg E, van Geloof WL, Veerkamp JH, van Muijen GNP, van Kuppevelt TH: Localization and characterization of melanoma-associated glycosaminoglycans: differential expression of chondroitin and heparan sulfate epitopes in melanoma. Cancer Res 2003, 63:2965-2970
15. Folberg R, Pe'er J, Gruman LM, Woolson RF, Jeng G, Montague PR, Moninger TO, Yi H, Moore KC: The morphologic charateristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study. Hum Pathol 1992, 23:1298-1305
16. Folberg R, Rummelt V, Parys-Van Ginderdeuren R, Hwang T, Woolson RF, Pe'er J, Gruman LM: The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 1993, 100:1389-1398
17. Sakamoto T, Sakamoto M, Yoshikawa H, Hata Y, Ishibashi T, Ohnishi Y, Inomata H: Histologic findings and prognosis of uveal malignant melanoma in Japanese patients. Am J Ophthalmol 1996, 121:276-283
18. Schaling DF, van der Pol JP, Schlingemann RO, Parys-Van Ginderdeuren R, Jager MJ, Schaling DF: Vascular Density and Vascular Patterns in the Prognosis of Choroidal Melanoma. Leiden, Rijksuniversiteit te Leiden, 1996, pp 43-54
19. McLean IW, Keefe KS, Burnier MN: Uveal melanoma: comparison of the prognostic value of fibrovascular loops, mean of the ten largest nucleoli, cell type and tumor size. Ophthalmology 1997, 104:777-780
20. Seregard S, Spangberg B, Juul C, Oskarsson M: Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma. Ophthalmology 1998, 105:485-491
21. Makitie T, Summanen P, Tarkkanen A, Kivela T: Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma. Invest Ophthalmol Vis Sci 1999, 40:2471-2480
22. Warso MA, Maniotis AJ, Chen X, Majumdar D, Patel MK, Shilkaitis A, Gupta TK, Folberg R: Prognostic significance of periodic acid-Schiff-positive patterns in primary cutaneous melanoma. Clin Cancer Res 2001, 7:473-477
23. Thies A, Mangold U, Moll I, Schumacher U: PAS-positive loops and networks as a prognostic indicator in cutaneous malignant melanoma. J Pathol 2001, 195:537-542
24. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, Radmacher M, Simon R, Yakhini Z, Ben-Dor A, Dougherty E, Wang E, Marincola F, Gooden C, Leuders J, Glatfelter A, Pollock P, Carpten J, Gillanders E, Leja D, Dietrich K, Beaudry C, Berens M, Alberts D, Sondak V, Hayward N, Trent J: Molecular classification of cutaneous melanoma by gene expression profiling. Nature 2000, 406:536-540
25. Seftor EA, Meltzer PS, Kirschmann DA, Pe'er J, Maniotis AJ, Trent JM, Folberg R, Hendrix MJC: Molecular determinants of human uveal melanoma invasion and metastasis. Clin Exp Metastasis 2002, 19:233-246
26. Maniotis AJ, Valyi-Nagy K, Karavitis J, Moses J, Boddipali V, Nunez R, Bissell MJ, Folberg R: Chromatin sensitivity to Alu I endonuclease is regulated by extracellular matrix and the cytoskeleton. Am J Pathol 2005, 166:1187-1203
27. McLean IW, Zimmerman LE, Evans RM: Reappraisal of Callender's spindle A type of malignant melanoma of choroid and ciliary body. Am J Ophthalmol 1978, 86:557-564
28. Callender GR: Malignant melanotic tumors of the eye: a study of histologic types in 111 cases. Trans Am Acad Ophthalmol Otolaryngol 1931, 36:131-142
29. Callender GR, Wilder HC, Ash JE: Five hundred malignant melanomas of the choroid and ciliary body followed five years or longer. Trans Am Acad Ophthalmol Otolaryngol 1942, 46:223-230
30. Kan-Mitchell J, Mitchell MS, Rao N, Liggett PE: Characterization of uveal melanoma cell lines that grow as xenografts in rabbit eyes. Invest Ophthalmol Vis Sci 1989, 30:829-834
31. Hendrix MJ, Seftor EA, Seftor RE, Fidler IJ: A simple quantitative assay for studying the invasive potential of high and low human metastatic variants. Cancer Lett 1987, 38:137-147
32. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264
33. McLean IW, Foster WD, Zimmerman LE, Gamel JW: Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol 1983, 96:502-509
34. Rummelt V, Folberg R, Woolson RF, Hwang T, Pe'er J: Relation between the microcirculation architecture and the aggressive behavior of ciliary body melanomas. Ophthalmology 1995, 102:844-851
35. Matysiak BE, Brodzeller T, Buck S, French A, Counts C, Boorsma B, Datta MW, Kajdacsy-Balla AA: Simple, inexpensive method for automating tissue microarray production provides enhanced microarray reproducibility. Appl Immunohistochem Mol Morphol 2003, 11:269-273
36. Seftor EA, Meltzer PS, Kirschmann DA, Pe'er J, Maniotis AJ, Trent JM, Folberg R, Hendrix MJC: Molecular determinants of uveal melanoma metastasis. Clin Exp Metastasis 2002, 19:233-246
37. McLean IW, Gamel JW: Prediction of metastasis of uveal melanoma: comparison of morphometric determination of nucleolar size and spectrophotometric determination of DNA. Invest Ophthalmol Vis Sci 1988, 29:507-511
38. Moshari A, McLean IW: Uveal melanoma: mean of the longest nucleoli measured on silver-stained sections. Invest Ophthalmol Vis Sci 2001, 42:1160-1163
39. Albertoni M, Shaw PH, Nozaki M, Godard S, Tenan M, Hamou MF, Fairlie DW, Breit SN, Paralkar VM, de Tribolet N, Van Meir EG, Hegi ME: Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1. Oncogene 2002, 21:4212-4219
40. Vidal MJ, Loganzo Jr F, de Oliveira AR, Hayward NK, Albino AP: Mutations and defective expression of the WAF1 p21 tumour-suppressor gene in malignant melanomas. Melanoma Res 1995, 5:243-250
41. Ozkurt IC, Tetradis S: Parathyroid hormone-induced E4BP4/NFIL3 down-regulates transcription in osteoblasts. J Biol Chem 2003, 278:26803-26809
42. Wolfgang CD, Liang G, Okamoto Y, Allen AE, Hai T: Transcriptional autorepression of the stress-inducible gene ATF3. J Biol Chem 2000, 275:16865-16870
43. Mueller BM, Yu YB, Laug WE: Overexpression of plasminogen activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid/scid mice. Proc Natl Acad Sci USA 1995, 92:205-209
44. Domenzain C, Docampo MJ, Serra M, Miquel L, Bassols A: Differential expression of versican isoforms is a component of the human melanoma cell differentiation process. Biochim Biophys Acta 2003, 1642:107-114
45. McCurdy J, Gamel J, McLean I: A simple, efficient, and reproducible method for estimating the malignant potential of uveal melanoma from routine H, E slides. Pathol Res Pract 1991, 187:1025-1027
46. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, Bissell MJ: Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 1997, 137:231-245
47. Wang F, Weaver VM, Petersen OW, Larabell CA, Dedhar S, Briand P, Lupu R, Bissell MJ: Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc Natl Acad Sci USA 1998, 95:14821-14826
48. Kenny PA, Bissell MJ: Tumor reversion: correction of malignant behavior by microenvironmental cues. Int J Cancer 2003, 107:688-695
49. Wang F, Hansen RK, Radisky D, Yoneda T, Barcellos-Hoff MH, Petersen OW, Turley EA, Bissell MJ: Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. J Natl Cancer Inst 2002, 94:1494-1503
50. Liu H, Radisky DC, Wang F, Bissell MJ: Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells. J Cell Biol 2004, 164:603-612
51. Kulesa PM, Kasemeier-Kulesa JC, Teddy JM, Margaryan NV, Seftor EA, Seftor RE, Hendrix MJ: Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment. Proc Natl Acad Sci USA 2006, 103:3752-3757
52. Mueller AJ, Freeman WR, Folberg R, Bartsch DU, Scheider A, Schaller, Kampik A: Evaluation of microvascularization pattern visibility in human choroidal melanomas: comparison of confocal fluorescein with indocyanine green angiography. Graefes Arch Clin Exp Ophthalmol 1999, 237:448-456
53. Clarijs R, van Dijk M, Ruiter DJ, de Waal RMW: Functional and morphologic analysis of the fluid-conducting meshwork in xenografted cutaneous and primary uveal melanoma. Invest Ophthalmol Vis Sci 2005, 46:3013-3020
54. Harrison JJ, Turner RJ, Ceri H: Persister cells, the biofilm matrix and tolerance to metal cations in biofilm and planktonic Pseudomonas aeruginosa. Environ Microbiol 2005, 7:981-994
55. Kaiserman I, Anteby I, Chowers I, Blumenthal EZ, Kliers I, Pe'er J: Post-brachytherapy initial tumour regression rate correlates with metastatic spread in posterior uveal melanoma. Br J Ophthalmol 2004, 88:892-895
56. Folberg R, Fleck M, Mehaffey MG, Meyer M, Bentler SE, Woolson RF, Pe'er J: Mapping prognostically significant vascular patterns in ciliary body and choroidal melanomas. Pathol Oncol Res 1996, 2:229-236
57. Mehaffey MG, Folberg R, Meyer M, Bentler SE, Hwang T, Woolson RF, Moore KC: Relative importance of quantifying area and vascular patterns in uveal melanoma. Am J Ophthalmol 1997, 123:798-809
58. Kujala E, Makitie T, Kivela T: Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci 2003, 44:4651-4659
59. McLean IW: The biology of haematogenous metastasis in human uveal malignant melanoma. Virchows Arch A Pathol Anat 1993, 422:433-437
60. Rummelt V, Mehaffey MG, Campbell RJ, Pe'er J, Bentler SE, Woolson RF, Naumann GOH, Folberg R: Microcirculation architecture of metastases from primary ciliary body and choroidal melanomas. Am J Ophthalmol 1998, 126:303-305